XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Other Working Capital Changes came in at -$753000.0 in Q1 2026, down 137.54% year-on-year from $2.0 million in Q1 2025, and down 242.34% quarter-over-quarter from $529000.0 in Q4 2025.

XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$753000.0 for Q1 2026.

  • Other Working Capital Changes for Q1 2026 came in at -$753000.0, down 137.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 52.48% YoY), and the FY2025 annual result was -$1.3 million, up 63.31% from the prior year.
  • Other Working Capital Changes came in at -$753000.0 for Q1 2026 at XOMA Royalty, down from $529000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q4 2022 to a low of -$2.4 million in Q3 2024.
  • The 5-year median for Other Working Capital Changes is -$217000.0 (2023), against an average of -$349529.4.
  • Across the five-year window, Other Working Capital Changes jumped 249.21% in 2022 and plunged 29133.33% in 2024, its largest moves.
  • XOMA Royalty's Other Working Capital Changes stood at $1.0 million in 2022, then plunged by 99.43% to $6000.0 in 2023, then slumped by 29133.33% to -$1.7 million in 2024, then jumped by 130.37% to $529000.0 in 2025, then sank by 242.34% to -$753000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$753000.0 (Q1 2026), $529000.0 (Q4 2025), and -$124000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -753,000.00
Mar 31, 2026 -753,000.00
Dec 31, 2025 529,000.00
Dec 31, 2025 529,000.00
Sep 30, 2025 -124,000.00
Sep 30, 2025 -124,000.00
Jun 30, 2025 -1.40 Mn
Jun 30, 2025 -1.40 Mn
Mar 31, 2025 -317,000.00
Mar 31, 2025 -317,000.00
Dec 31, 2024 -1.74 Mn
Dec 31, 2024 -1.74 Mn
Sep 30, 2024 -2.43 Mn
Sep 30, 2024 -2.43 Mn
Jun 30, 2024 816,000.00
Jun 30, 2024 816,000.00
Mar 31, 2024 -213,000.00
Mar 31, 2024 -213,000.00
Dec 31, 2023 6,000.00
Dec 31, 2023 6,000.00